2015
DOI: 10.1016/j.yrtph.2014.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: Alternative approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
27
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(27 citation statements)
references
References 69 publications
0
27
0
Order By: Relevance
“…DNA methylating agents such as N -methyl- N -nitrosourea (MNU), N -nitrosodimethylamine (NDMA), and Temozolomide (TMZ) form DNA lesions that are both toxic and mutagenic. One of those lesions is O 6 -methylguanine (m6G), which is potently mutagenic because it predominantly pairs with thymine during replication. , There is much interest in these agents in the fields of environmental and clinical toxicology, because DNA methylating agents are contaminants found in and around toxic waste sites; they form in preserved foods and beverages; they form during carbon capture processes; , they are contaminants in cardiovascular and other medications; and they are present in tobacco smoke and other tobacco products. , Similarly, there is interest in the field of cancer therapy because the lead agent used in treatment of glioblastoma, TMZ, forms m6G as a critical component of its mechanism of action. …”
Section: Introductionmentioning
confidence: 99%
“…DNA methylating agents such as N -methyl- N -nitrosourea (MNU), N -nitrosodimethylamine (NDMA), and Temozolomide (TMZ) form DNA lesions that are both toxic and mutagenic. One of those lesions is O 6 -methylguanine (m6G), which is potently mutagenic because it predominantly pairs with thymine during replication. , There is much interest in these agents in the fields of environmental and clinical toxicology, because DNA methylating agents are contaminants found in and around toxic waste sites; they form in preserved foods and beverages; they form during carbon capture processes; , they are contaminants in cardiovascular and other medications; and they are present in tobacco smoke and other tobacco products. , Similarly, there is interest in the field of cancer therapy because the lead agent used in treatment of glioblastoma, TMZ, forms m6G as a critical component of its mechanism of action. …”
Section: Introductionmentioning
confidence: 99%
“…Until more research on the potential effects of specific components is done, their presence, even in very concentrations, requires monitoring. An example here is nitrosamines, a group of generally carcinogenic compounds . However, few studies are available for the nitrosamines that are typically formed in the CO 2 capture process.…”
Section: Environmental and Health Aspects Of Some Degradation Compoundsmentioning
confidence: 99%
“…N-Nitrosamine GTIs have been recognized as a kind of potent carcinogens. They showed mutagenic activities in Ames test with Salmonella typhimurium and triggered the carcinogenic effect in rats, mice, hamsters, guinea pigs, and rabbits (Wagner et al 2012;Santos et al 2014;Buist et al 2015;Ravnum et al 2014). Since the valsartan and losartan products produced by several pharmaceutical companies were proven to contain potential contamination with carcinogenic nitrosamine impurities, namely, N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), and N-nitroso-N-methyl-4-aminobutyric acid (NMBA) ( Fig.…”
Section: Introductionmentioning
confidence: 99%